Connect with us

Health

FDA approves clinical trials to test the safety of cancer-detection technology – News-Medical.Net

The U.S. Food and Drug Administration has approved human clinical trials to test the safety of cancer-detection technology developed at Case Western Reserve University:…

Published

on

Article feature image

The U.S. Food and Drug Administration has approved human clinical trials to test the safety of cancer-detection technology developed at Case Western Reserve University: a tumor-targeting contrast agent that accurately detects aggressive prostate cancer in a magnetic resonance imaging (MRI) scan.
The molecular-targeted imaging agent is licensed to Molecular Theranostics LLC, a Cleveland based startup company, and its partners U.S. Motek LLC and Jiangsu Motek Pharmaceuticals Ltd. of China.
The agent…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Study could help understand how Tuberous Sclerosis Complex arises – News-Medical.net
Article feature image
Scientists identify molecular mechanism behind weight gain in patients taking antipsychotics – News-Medical.Net